Wall Street Experts
ver. ZuMIgo(08/25)
Madrigal Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 78
EBIT TTM (mln): -504
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
Rok finansowy |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
3 |
144 |
15 |
8 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
180 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
-86.7% |
-100.0% |
0.0% |
inf% |
252.0% |
5416.1% |
-89.7% |
-48.8% |
-98.1% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
Marża brutto |
0.0% |
0.0% |
100.0% |
100.0% |
0.0% |
0.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
96.5% |
EBIT (mln) |
-0 |
-36 |
-28 |
-47 |
-71 |
-59 |
-66 |
-94 |
79 |
-37 |
-45 |
-61 |
-88 |
-84 |
-68 |
-25 |
-32 |
-41 |
-95 |
-207 |
-242 |
-294 |
-380 |
-498 |
EBIT Δ r/r |
0.0% |
8943.4% |
-22.0% |
65.9% |
51.7% |
-16.9% |
11.9% |
41.5% |
-184.6% |
-146.5% |
23.1% |
34.1% |
43.7% |
-4.1% |
-19.5% |
-62.7% |
27.1% |
26.9% |
133.4% |
117.6% |
17.3% |
21.1% |
29.6% |
30.8% |
EBIT (%) |
0.0% |
0.0% |
-2169.8% |
-27126.6% |
0.0% |
0.0% |
-8912.0% |
-3583.5% |
55.0% |
-249.3% |
-599.1% |
-41456.5% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-276.4% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
1 |
2 |
2 |
3 |
2 |
1 |
1 |
1 |
8 |
11 |
0 |
0 |
4 |
13 |
15 |
EBITDA (mln) |
-0 |
11 |
-28 |
-43 |
-71 |
-57 |
-66 |
-91 |
84 |
-35 |
-44 |
-60 |
-87 |
-83 |
-67 |
-25 |
-32 |
-41 |
-95 |
-207 |
-242 |
-291 |
-380 |
-450 |
EBITDA(%) |
0.0% |
0.0% |
-2124.5% |
-24977.5% |
0.0% |
0.0% |
-8827.2% |
-3479.6% |
58.4% |
-236.2% |
-579.7% |
-40954.4% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-249.9% |
Podatek (mln) |
0 |
-18 |
-0 |
1 |
-2 |
-2 |
-3 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
-1 |
8 |
-11 |
-5 |
-1 |
4 |
0 |
0 |
Zysk Netto (mln) |
-0 |
-36 |
-28 |
-46 |
-69 |
-57 |
-63 |
-93 |
79 |
-37 |
-47 |
-63 |
-90 |
-86 |
-69 |
-26 |
-31 |
-33 |
-73 |
-197 |
-241 |
-299 |
-374 |
-466 |
Zysk netto Δ r/r |
0.0% |
9389.2% |
-22.9% |
64.8% |
49.9% |
-16.8% |
10.9% |
45.9% |
-185.4% |
-147.4% |
26.5% |
32.5% |
43.6% |
-4.5% |
-20.3% |
-61.6% |
18.1% |
5.3% |
121.9% |
171.2% |
22.1% |
24.2% |
24.8% |
24.7% |
Zysk netto (%) |
0.0% |
0.0% |
-2137.9% |
-26551.4% |
0.0% |
0.0% |
-8545.8% |
-3541.8% |
54.8% |
-253.1% |
-624.7% |
-42714.3% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-258.6% |
EPS |
-4.55 |
-105.09 |
-44.65 |
-85.96 |
-108.31 |
-90.03 |
-68.45 |
-96.09 |
81.55 |
-32.49 |
-35.14 |
-36.99 |
-44.48 |
-30.62 |
-401.56 |
-5.07 |
-2.54 |
-2.22 |
-4.73 |
-12.78 |
-14.58 |
-17.47 |
-19.99 |
-21.9 |
EPS (rozwodnione) |
-4.55 |
-105.09 |
-44.65 |
-85.96 |
-108.31 |
-90.03 |
-68.45 |
-96.09 |
81.2 |
-32.49 |
-35.14 |
-36.99 |
-44.48 |
-30.62 |
-401.56 |
-5.07 |
-2.54 |
-2.22 |
-4.73 |
-12.78 |
-14.58 |
-17.47 |
-19.99 |
-21.9 |
Ilośc akcji (mln) |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
2 |
3 |
0 |
5 |
12 |
15 |
15 |
15 |
17 |
17 |
19 |
21 |
Ważona ilośc akcji (mln) |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
2 |
3 |
0 |
5 |
12 |
15 |
15 |
15 |
17 |
17 |
19 |
21 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |